Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD. He adds that AI supports drug repurposing by uncovering new actionable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results